Back to News
Market Impact: 0.15

Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®

Source: PR Newswire

Healthcare & BiotechProduct LaunchesTechnology & Innovation

Meant Health announced an expansion of its digital-health telehealth platform to provide access to FDA-approved GLP-1 medications, connecting patients with licensed clinicians for evaluation, prescriptions and ongoing care coaching. The expansion broadens the company’s obesity and metabolic-care offering, but the release provides no financial targets, patient volumes, pricing, or expected revenue impact.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

More News